← Insider buys

IART

Integra LifeSciences Holdings Corporation · Healthcare

Insiders bought $102K of Integra LifeSciences Holdings Corporation in the last 12 months

1 insider bought on 1 day.

$102KBought, 12 mo
$0Sold, 12 mo
$1.0BMarket cap

IART over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

IART after insider buys

3 months after each buy, from the first price a copier could get.

−8.9%Average
−14.4 ptsVs S&P 500
2 of 5Higher

5 buys since 2017 with 3 months of prices.

Congress

Members reported 5 trades in IART since 2023.

Every filing

119 insider filings since 2016, newest first

IARTSell

Stuart Essig · Director

$7.7M−7.0%May 28
IARTSell

Stuart Essig · Director

$109KMay 14
IARTSell

Daniel L. Reuvers · Cvp,pres - Codman SPC Surgical

$1.2M−35.0%May 13
IARTSell

Peter J Arduini · President and CEO

$1.8M−12.0%Feb 28
IARTSell

Peter J Arduini · President and CEO

$4.9M−26.0%Feb 25
IARTSell

Richard E Caruso · 10% owner

$29.2M−4.0%Dec 20
IARTSell

Eric Schwartz · Corp VP, GC, Sec

$247K−11.0%Dec 5
IARTSell

Richard E Caruso · 10% owner

$31.7M−4.0%Sep 20
IARTSell

John Mooradian · Corp VP, Global Ops, Supp Chn

$578K−38.0%Sep 13
IARTSell

Joseph Vinhais · Corp VP,Quality, Transformatio

$58K−10.0%Sep 13
IARTSell

Peter J Arduini · President and CEO

$15.1M−58.0%Sep 10
IARTSell

John Mooradian · Corp VP, Global Ops, Supp Chn

$430K−31.0%Aug 26
IARTSell

Richard E Caruso · 10% owner

$4.9M−1.0%Aug 26
IARTSell

Raymond G. Murphy · Director

$252K−6.0%Aug 20
IARTSell

Jeffrey Mosebrook · Principal Accounting Officer

$75K−14.0%Jul 31
IARTSell

Kenneth Burhop · Corpvp,chiefscientific Officer

$426K−35.0%Jul 31
IARTSell

Lisa Evoli · CHRO

$150K−48.0%Jul 30
IARTSell

Glenn Coleman · CVP, COO

$201K−9.0%Jul 26
IARTSell

Robert T. Davis Jr. · Cvp,pres-ortho, Tissue TECH

$1.3M−36.0%Jul 26
IARTSell

Daniel L. Reuvers · Cvp,pres - Codman SPC Surgical

$300K−12.0%Jul 26
IARTSell

Glenn Coleman · CVP, COO

$201K−13.0%Jul 2
IARTSell

Christian S Schade · Director

$807K−32.0%May 14
IARTSell

Lisa Evoli · CHRO

$72K−21.0%Mar 18
IARTBuy

Rhonda Germany Ballintyn · Director

$108K+58.0%Mar 18
IARTSell

Richard E Caruso · 10% owner

$1.7MMar 15
IARTSell

Richard E Caruso · 10% owner

$2.9MOct 18
IARTSell

Glenn Coleman · CVP, CFO

$562K−35.0%Aug 10
IARTSell

Jeffrey Mosebrook · Principal Accounting Officer

$62K−12.0%Aug 10
IARTSell

Lisa Evoli · CHRO

$280K−59.0%Aug 10
IARTSell

Stuart Essig · Director

$4.4M−3.0%Jul 25
IARTSell

Stuart Essig · Director

$2.0M−2.0%Jul 19
IARTSell

Stuart Essig · Director

$10.2M−7.0%Jul 11
IARTSell

Daniel L. Reuvers · Cvp,pres - Codman SPC Surgical

$67K−4.0%Jun 19
IARTSell

Daniel L. Reuvers · Cvp,pres - Codman SPC Surgical

$62K−4.0%May 1
IARTSell

Glenn Coleman · CVP, CFO

$492K−21.0%Mar 15
IARTSell

Joseph Vinhais · Corp VP, Global Qlty Assurance

$368K−47.0%Mar 12
IARTSell

Richard E Caruso · 10% owner

$1.8MMar 12
IARTSell

James M Sullivan · Director

$823K−21.0%Mar 8
IARTSell

Christian S Schade · Director

$828K−35.0%Mar 6
IARTSell

Keith Bradley · Director

$861K−30.0%Feb 27
IARTSell

Richard D. Gorelick · Corp VP, GC, Sec

$71K−7.0%Nov 15
IARTBuy

Barbara B Hill · Director

$502K+24.0%Nov 1
IARTBuy

Donald E Morel Jr · Director

$492K+37.0%Aug 4
IARTBuy

Barbara B Hill · Director

$249K+13.0%Aug 2
IARTSell

Stuart Essig · Director

$6.7M−6.0%May 26
IARTSell

Stuart Essig · Director

$6.7M−7.0%May 24
IARTSell

Glenn Coleman · CVP, CFO

$637K−43.0%May 5
IARTSell

James M Sullivan · Director

$719K−22.0%May 5
IARTSell

Glenn Coleman · CVP, CFO

$193K−10.0%Mar 17
IARTSell

Joseph Vinhais · Corp VP,Global Qlty Assurance

$73K−14.0%Mar 17
About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.